0 results available. Select is focused ,type to refine list, press Down to open the menu,
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune ce...
The following section summarizes insights on Regen BioPharma Inc's 4 Year Price Total Return:
We've identified the following companies as similar to Regen BioPharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to 4 Year Price Total Return in the valuation category include:
The total change in price (adjusted of dividends and splits when applicable) over the last 4 years.
The 4 year price total return measures the total change in price (adjusted of dividends and splits when applicable) over the last 4 years. If the company pays dividends, the starting stock price is adjusted down to include the return in the form of dividends.
Last Close Price / Adj Prior Close Price
(-) 1
(=) Total Return
Four Year Stock Price Total Return for Regen BioPharma is calculated as follows:
Last Close Price [ 0.050 ] / Adj Prior Close Price [ 1.65 ]
(-) 1
(=) Total Return [ −97.0% ]
Prior price dividend adjustment factor is 1.00.
Read more about price close (split adjusted) and dividend adjustment factor
The chart above depicts the distribution of 4 year price total return for companies operating in the Healthcare sector in the Developed economic region. Over 3,140 companies were considered in this analysis, and 3,017 had meaningful values. The average 4 year price total return of companies in the sector is -56.9% with a standard deviation of 55.4%.
Regen BioPharma Inc's 4 Year Price Total Return of -97.0% ranks in the 25.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,142 |
| Included Constituents | 3,017 |
| Min | -100.0% |
| Max | 203.8% |
| Median | -80.3% |
| Mean | -56.9% |
| Standard Deviation | 55.4% |
You can find companies with similar 4 year price total return using this stock screener.